Spanish Drugmakers See Austerity Reducing 2012 Sales by 15%

Spanish drugmakers’ sales may drop 10 percent this year and more than 15 percent in 2012 because of government spending cuts amid the nation’s worst economic crisis in decades, the lobbying group Farmaindustria said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.